Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also weighed in on RGLS. Canaccord Genuity Group increased their target price on Regulus Therapeutics from $9.00 to $12.00 and gave […]
More Stories
SPDR Bloomberg Barclays International Treasury Bond ETF (NYSEARCA:BWX) Sees Large Volume Increase – Time to Buy?
SPDR Bloomberg Barclays International Treasury Bond ETF (NYSEARCA:BWX – Get Free Report) shares saw unusually-strong trading volume on Monday ....
LandBridge (NYSE:LB) Shares Down 9% – Time to Sell?
LandBridge Co LLC (NYSE:LB – Get Free Report) traded down 9% on Monday . The company traded as low as...
Short Interest in Tessenderlo Group NV (OTCMKTS:TSDOF) Drops By 70.0%
Tessenderlo Group NV (OTCMKTS:TSDOF – Get Free Report) was the target of a large decrease in short interest in December....
Invesco National AMT-Free Municipal Bond ETF (NYSEARCA:PZA) Sees Large Volume Increase – Still a Buy?
Invesco National AMT-Free Municipal Bond ETF (NYSEARCA:PZA – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately...
Tertiary Minerals (LON:TYM) Sets New 12-Month Low – Time to Sell?
Tertiary Minerals plc (LON:TYM – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The...
Plato Gold (CVE:PGC) Sets New 12-Month High – Still a Buy?
Plato Gold Corp. (CVE:PGC – Get Free Report)’s stock price reached a new 52-week high during trading on Monday ....